If you are having trouble viewing this email, please view it on our website.

         
 
A Service Announcement from Pharmexec
  Applied Clinical Trials  
     
   
 
Post- Approval Summit May 10-11, 2011

Last Chance to Register at the Early Registration Rate!

This is the last week to save $300 on registration to the Post-Approval Summit! Don't miss out. Register by March 11 to receive the early registration discount.

The 2011 Summit agenda will cover:

• Real-World Research
• Safety and Surveillance
• Benefit-Risk Management and REMS
• Comparative Effectiveness Research

Keynote presentations will be delivered by the FDA and CMS, reflecting on the impact of post-approval initiatives and new approaches to evidence synthesis for safety in the age of effectiveness.

Other confirmed speakers represent:

AHRQ European Medicines Agency
NICE Janssen-Ortho
NHLBI Merck
Canadian Institutes of Health Research American Society of Plastic Surgeons
Consumers Union American Society of Clinical Oncology
CVS Caremark Corporation Academy of Ophthalmology
Harvard Medical School Outcome
Takeda King Pharmaceuticals

To learn more or to view the full agenda, please visit the Summit website at http://www.postapproval.org/agenda.htm


Register Today!


Register online at www.postapproval.org. Register by March 11 and save $300! Your registration includes all conference materials, breakfast and lunch on both days, and admittance to the opening night reception at Boston's Skywalk Observatory.

We look forward to seeing you in May!

Best Regards,

The Committee for the Post-Approval Summit
201 Broadway, Cambridge, MA 02139
Tel: (617) 621-64261 617 621 6426
Fax: (617) 621-1620
mailto: [email protected]
United States

 
If you no longer wish to receive emails from Post-Approval , please reply to [email protected]
 
 

ACT is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.